Inhibition of cancer cell proliferation by midazolam by targeting transient receptor potential melastatin 7

Oncology Letters

Volumn 5, Issue 3, 2013, Pages 1010-1016

  Dou, Yunling ^a,b   Li, Yuan ^a   Chen, Jingkao ^a   Wu, Sihan ^a   Xiao, Xiao ^a   Xie, Shanshan ^a   Tang, Lipeng ^a   Yan, Min ^a   Wang, Youqiong ^a   Lin, Jun ^c   Zhu, Wenbo ^a   Yan, Guangmei ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c Downstate Health Sciences University   (United States)

Author keywords

Cell cycle arrest; Human head and neck carcinoma; Midazolam; Proliferation; Transient receptor potential melastatin 7

Indexed keywords

BENZODIAZEPINE RECEPTOR; CLONAZEPAM; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN E; DIAZEPAM; FLUMAZENIL; MESSENGER RNA; MIDAZOLAM; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE C 11; PROTEIN P21; PROTEIN P27; RETINOBLASTOMA PROTEIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL M;

ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL COUNT; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; HYPOPHARYNX CARCINOMA; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

EID: 84872695388     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1129     Document Type: Article

References (29)

1. 2+ for cancer cell proliferation and survival. Nat Rev Cancer 8: 361-375, 2008.
2. 2+ transport. Nat Rev Cancer 7: 519-530, 2007.
3. Capiod T: Cell proliferation, calcium influx and calcium channels. Biochimie 93: 2075-2079, 2011.
4. Bödding M: TRP proteins and cancer. Cell Signal 19: 617-624, 2007.
5. Jiang J, Li MH, Inoue K, Chu XP, Seeds J and XiongZG: Transient receptor potential melastatin 7-like current in human head and neck carcinoma cells: role in cell proliferation. Cancer Res 67: 10929-10938, 2007.
6. Zhu W, Ou Y, Li Y, et al: A small-molecule triptolide suppresses angiogenesis and invasion of human anaplastic thyroid carcinoma cells via down-regulation of the nuclear factor-kappa B pathway. Mol Pharmacol 75: 812-819, 2009.
7. Evan GI and Vousden KH: Proliferation, cell cycle and apoptosis in cancer. Nature 411: 342-348, 2001.
8. Ramsey IS, Delling M and Clapham DE: An introduction to TRP channels. Annu Rev Physiol 68: 619-647, 2006.
9. Carafoli E: Calcium signaling: a tale for all seasons. Proc Natl Acad Sci USA 99: 1115-1122, 2002.
10. Santoni G and Farfariello V: TRP channels and cancer: new targets for diagnosis and chemotherapy. Endocr Metab Immune Disord Drug Targets 11: 54-67, 2011.
11. Prevarskaya N, Zhang L and Barritt G: TRP channels in cancer. Biochim Biophys Acta 1772: 937-946, 2007.
12. Gao H, Chen X, Du X, Guan B, Liu Y and Zhang H: EGF enhances the migration of cancer cells by up-regulation of TRPM7. Cell Calcium 50: 559-568, 2011.
13. 2+-sensitive Socs3a signaling in development and cancer. Dis Model Mech 4: 240-254, 2011.
14. Guilbert A, Gautier M, Dhennin-Duthille I, Haren N, Sevestre H and Ouadid-Ahidouch H: Evidence that TRPM7 is required for breast cancer cell proliferation. Am J Physiol Cell Physiol 297: C493-C502, 2009.
15. Kahl CR and Means AR: Regulation of cell cycle progression by calcium/calmodulin-dependent pathways. Endocr Rev 24: 719-736, 2003.
16. Takuwa N, Zhou W, Kumada M and Takuwa Y: Ca(2+)-dependent stimulation of retinoblastoma gene product phosphorylation and p34cdc2 kinase activation in serum-stimulated human fibroblasts. J Biol Chem 268: 138-145, 1993.
17. 2+/CaM kinase). Cell Growth Differ 6: 1063-1070, 1995.
18. Morris TA, DeLorenzo RJ and Tombes RM: CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells. Exp Cell Res 240: 218-227, 1998.
19. Ben-Eliyahu S: The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology. Brain Behav Immun 17 (Suppl 1): S27-S36, 2003.
20. Ben-Eliyahu S, Page GG, Yirmiya R and Shakhar G: Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer 80: 880-888, 1999.
21. Goldfarb Y and Ben-Eliyahu S: Surgery as a risk factor for breast cancer recurrence and metastasis: mediating mechanisms and clinical prophylactic approaches. Breast Dis 26: 99-114, 2006.
22. Exadaktylos AK, Buggy DJ, Moriarty DC, Mascha E and SesslerDI: Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology 105: 660-664, 2006.
23. Melamed R, Bar-Yosef S, Shakhar G, Shakhar K and Ben-Eliyahu S: Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth Analg 97: 1331-1339, 2003.
24. Arain MR and Buggy DJ: Anaesthesia for cancer patients. Curr Opin Anaesthesiol 20: 247-253, 2007.
25. Gupta K, Kshirsagar S, Chang L, Schwartz R, Law PY, Yee D and Hebbel RP: Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res 62: 4491-4498, 2002.
26. Stepien H, Pawlikowska A and Pawlikowski M: Effects of benzodiazepines on thymus cell proliferation. Thymus 12: 117-121, 1988-1989.
27. Bruce JH, Ramirez AM, Lin L, Oracion A, Agarwal RP and NorenbergMD: Peripheral-type benzodiazepines inhibit proliferation of astrocytes in culture. Brain Res 564: 167-170, 1991.
28. Kletsas D, Li W, Han Z and Papadopoulos V: Peripheral-type benzodiazepine receptor (PBR) and PBR drug ligands in fibroblast and fibrosarcoma cell proliferation: role of ERK, c-Jun and ligand-activated PBR-independent pathways. Biochem Pharmacol 67: 1927-1932, 2004.
29. Gorman AM, O'Beirne GB, Regan CM and WilliamsDC: Antiproliferative action of benzodiazepines in cultured brain cells is not mediated through the peripheral-type benzodiazepine acceptor. J Neurochem 53: 849-855, 1989.